IL1B and eosinophilia-myalgia syndrome: A hallmark of EMs is sustained inflammation, characterized by elevated levels of proinflammatory mediators (NLRP3, caspase-1, and IL-1β) in ectopic lesions, which promote cell proliferation, angiogenesis, and fibrosis.